GO:0043536 positive regulation of blood vessel endothelial cell migration: Angiogenesis Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043536 describes any process that activates or increases the frequency, rate or extent of blood vessel endothelial cell migration, a central step in angiogenesis.
• Endothelial cell migration is driven by tip-cell selection, filopodia extension and directional guidance, processes that require BMPR2 signaling and biomechanical coordination.
• VEGFA is a master pro-migratory cue, and its induction by NF-κB downstream of B7-H3 directly promotes endothelial migration and tumor angiogenesis.
• High endothelial venules are specialized blood vessels whose remodeling and immune-cell entry are linked to ALOX12 and CCR7+ CD8+ T-cell recruitment in tumors [3,6].
• Endothelial LRRC8A and B2M have been identified as regulators of coronary angiogenesis and pulmonary hypertension, showing that GO:0043536 is relevant beyond oncology [4,5].
• miRNAs fine-tune endothelial migration by modulating tumor-endothelial crosstalk, making them attractive tools for functional screens.
Description
GO:0043536, positive regulation of blood vessel endothelial cell migration, is a biological process term that captures any signal or molecular event that increases the frequency, rate or extent of endothelial cell movement within blood vessels. Endothelial migration is not a passive response; it is an actively regulated, directional process that underlies sprouting angiogenesis, vascular repair and pathological neovascularization. Because endothelial cells form the inner lining of every blood vessel, their migration determines how new vascular networks are built and how existing ones are remodeled. Researchers study GO:0043536 to understand normal vascular development and to identify therapeutic targets in cancer, cardiovascular disease and chronic inflammatory conditions [1,4,5]. The term is defined by its positive regulatory outcome rather than by a single molecular mechanism, so many upstream pathways can contribute, including growth factor signaling, transcription factor activation and extracellular matrix remodeling [1,7]. This article integrates the QuickGO definition with verified PubMed literature to provide a publication-ready overview of the genes, mechanisms, disease links and experimental models associated with GO:0043536.
positive regulation of blood vessel endothelial cell migration At A Glance
| GO ID | GO:0043536 |
|---|---|
| GO term | positive regulation of blood vessel endothelial cell migration |
| Ontology | biological_process |
| Synonym | activation of blood vessel endothelial cell migration; stimulation of blood vessel endothelial cell migration; up regulation of blood vessel endothelial cell migration; up-regulation of blood vessel endothelial cell migration; upregulation of blood vessel endothelial cell migration |
| Major function | Increases the frequency, rate or extent of endothelial cell migration in blood vessels, thereby promoting angiogenesis and vascular remodeling |
| Biological context | Sprouting angiogenesis, tumor angiogenesis, coronary angiogenesis, high endothelial venule remodeling and vascular repair |
| Representative regulators | VEGFA, NF-κB, B7-H3, BMPR2, LRRC8A, B2M, ALOX12 and miRNAs |
| Disease relevance | Cancer, pulmonary hypertension, cardiac hypertrophy and immune evasion in lymph nodes |
| Research methods | Endothelial migration assays, live imaging, RNA-seq, proteomics, CRISPR knockout and overexpression models |
What Is GO:0043536?
According to QuickGO, GO:0043536 is defined as any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels. In practical terms, it is the positive-control arm of endothelial motility: it includes signals that make endothelial cells move faster, farther or more directionally during blood vessel formation and remodeling. The term is a biological process and is closely related to angiogenesis, sprouting angiogenesis and endothelial cell chemotaxis. Synonyms include activation of blood vessel endothelial cell migration, stimulation of blood vessel endothelial cell migration, up regulation of blood vessel endothelial cell migration, up-regulation of blood vessel endothelial cell migration and upregulation of blood vessel endothelial cell migration.
Why Is positive regulation of blood vessel endothelial cell migration Important in Cell Biology?
GO:0043536 is important because endothelial cell migration is a rate-limiting step in angiogenesis, and angiogenesis contributes to both normal physiology and numerous diseases. In cancer, tumors induce pro-migratory signals such as VEGFA to recruit new blood vessels and sustain growth. In cardiovascular disease, impaired or excessive endothelial migration can contribute to pulmonary hypertension and cardiac hypertrophy [4,5]. In immunity, specialized high endothelial venules regulate lymphocyte entry, and their remodeling can influence immune evasion or immunotherapy response [3,6]. Therefore, understanding the positive regulation of blood vessel endothelial cell migration provides mechanistic insight into disease progression and identifies candidate targets for anti-angiogenic, cardiovascular and immuno-oncology therapies.
• Endothelial cell migration is essential for sprouting angiogenesis and the formation of new blood vessels.
• VEGFA-induced endothelial migration is a key mechanism of tumor angiogenesis and is regulated by NF-κB signaling.
• BMPR2 controls endothelial tip-cell position, filopodia formation and biomechanics, which are required for directed migration.
• LRRC8A in endothelial cells promotes coronary angiogenesis and protects against pressure overload-induced cardiac hypertrophy.
• B2M has been identified as a regulator of pulmonary hypertension in heart failure with preserved ejection fraction, linking endothelial biology to cardiopulmonary disease.
• ALOX12-dependent remodeling of tumor-associated high endothelial venules drives portal-specific immune evasion in lymph nodes.
• Anti-angiogenic therapy combined with immune checkpoint blockade can mediate CCR7+ CD8+ T-cell entry into hepatocellular carcinoma through high endothelial venules.
• miRNAs modulate tumor and endothelial cell interactions during tumor progression, affecting migratory behavior.
• GO:0043536 is a useful annotation for interpreting transcriptomic and proteomic changes in vascular disease models [4,5].
• Targeting positive regulators of endothelial migration may improve anti-angiogenic therapy or promote vascular repair [1,5].
What Happens During positive regulation of blood vessel endothelial cell migration?
Initiation by pro-migratory signals
In simple terms: The process starts when signals outside the cell tell endothelial cells to move.
Positive regulation of blood vessel endothelial cell migration begins with extracellular cues such as growth factors, cytokines and matrix-bound molecules that activate endothelial cell surface receptors. VEGFA is a central pro-migratory signal, and its expression can be induced by NF-κB activation downstream of B7-H3 in colorectal cancer, leading to increased angiogenesis. These signals convert endothelial cells from a quiescent, stable state into a migratory phenotype, a transition that is fundamental to sprouting angiogenesis.
Tip-cell selection and filopodia formation
In simple terms: Some endothelial cells take the lead and grow tiny finger-like extensions to explore the environment.
During sprouting, endothelial cells adopt specialized positions: tip cells lead the sprout while stalk cells follow. BMPR2 expression and signaling are required for correct endothelial tip-cell position, filopodia formation and biomechanics, and loss of BMPR2 impairs these migratory features. Filopodia are actin-rich protrusions that sense guidance cues and help direct migration toward pro-angiogenic stimuli. This step is a key point where positive regulation of blood vessel endothelial cell migration is spatially and mechanically controlled.
Directional migration and vascular guidance
In simple terms: The leading cells move in a coordinated direction to build a new vessel branch.
Once tip cells are specified, they migrate directionally along gradients of pro-angiogenic factors and extracellular matrix components. This directional movement requires coordinated cytoskeletal dynamics, cell-matrix adhesion and cell-cell communication between tip and stalk cells [2,7]. Positive regulators of this process increase the speed, persistence or frequency of endothelial migration, thereby promoting sprout elongation and new vessel formation.
Integration with vessel remodeling and immune-vascular crosstalk
In simple terms: Migrating endothelial cells help reshape blood vessels and can influence immune cell entry.
Endothelial migration is not isolated; it is integrated with vessel remodeling and immune cell trafficking. High endothelial venules are specialized blood vessels that support lymphocyte entry, and their remodeling can be driven by ALOX12 in tumor-associated lymph nodes, contributing to immune evasion. In hepatocellular carcinoma, anti-angiogenic therapy combined with immune checkpoint blockade mediates CCR7+ CD8+ T-cell entry through high endothelial venules. These findings show that positive regulation of blood vessel endothelial cell migration can shape both vascular architecture and anti-tumor immunity.
Resolution and stabilization
In simple terms: After moving, endothelial cells stabilize the new vessel and return to a resting state.
Successful migration must eventually resolve into a stable, perfused vessel. This involves pruning of excess sprouts, deposition of basement membrane and re-establishment of endothelial quiescence. Positive regulation of blood vessel endothelial cell migration is therefore balanced by negative regulatory mechanisms that prevent excessive or disorganized angiogenesis. In disease, this balance can be disrupted, leading to pathological neovascularization or vascular insufficiency [1,4,5].
Key Genes Involved in GO:0043536 positive regulation of blood vessel endothelial cell migration
The following genes and proteins have been experimentally linked to positive regulation of blood vessel endothelial cell migration or closely related angiogenic processes in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VEGFA | Master pro-angiogenic growth factor that induces endothelial migration and angiogenesis | Central target for anti-angiogenic therapy and tumor angiogenesis studies |
| NF-κB | Transcription factor that induces VEGFA expression downstream of B7-H3 | Links inflammation and angiogenesis; candidate for pathway inhibition |
| B7-H3 | Immune checkpoint molecule that promotes colorectal cancer angiogenesis via NF-κB/VEGFA | Potential target in immuno-oncology and angiogenesis research |
| BMPR2 | Receptor required for endothelial tip-cell position, filopodia formation and biomechanics | Key gene for sprouting angiogenesis and pulmonary vascular disease models |
| LRRC8A | Endothelial ion channel that promotes coronary angiogenesis and mitigates cardiac hypertrophy | Candidate for cardiovascular angiogenesis research |
| B2M | Plasma protein identified as a regulator of pulmonary hypertension in HFpEF | Biomarker and functional candidate in cardiopulmonary disease |
| ALOX12 | Lipoxygenase involved in tumor-associated high endothelial venule remodeling and immune evasion | Target for understanding lymph node immune evasion |
| CCR7 | Chemokine receptor mediating T-cell entry through high endothelial venules | Relevant to immunotherapy and vascular-immune crosstalk |
| CD8 | T-cell marker used to track CCR7+ CD8+ T-cell entry into tumors | Readout for immune-vascular interactions |
| miRNAs | Post-transcriptional regulators of tumor-endothelial crosstalk and migration | Tool for functional screens and therapeutic modulation |
| Endothelial tip cells | Leading cells of angiogenic sprouts that guide migration [2,7] | Cellular model for studying directed endothelial migration [2,7] |
| Stalk cells | Trailing endothelial cells that support sprout elongation | Used to study cell-fate specification during angiogenesis |
| Extracellular matrix | Provides adhesive and guidance cues for migrating endothelial cells | Substrate for in vitro migration assays |
| Filopodia | Actin-rich protrusions that sense guidance cues during migration | Readout for cytoskeletal and biomechanical studies |
| High endothelial venules | Specialized vessels that support lymphocyte entry and can be remodeled in tumors [3,6] | Model for vascular-immune crosstalk [3,6] |
How Is positive regulation of blood vessel endothelial cell migration Regulated?
Positive regulation of blood vessel endothelial cell migration is controlled at multiple levels. Extracellularly, growth factors such as VEGFA and guidance cues activate receptor tyrosine kinases and downstream signaling cascades [1,2]. Transcriptionally, NF-κB induces VEGFA expression in response to B7-H3, linking immune checkpoint signaling to angiogenic gene expression. Mechanotransduction and cell-cell communication determine tip-cell selection and filopodia formation, with BMPR2 playing a critical role. Ion transport, exemplified by LRRC8A, can also modulate endothelial migration and coronary angiogenesis. Post-transcriptional regulation by miRNAs fine-tunes the migratory response and tumor-endothelial crosstalk. Together, these layers ensure that endothelial migration is transient, directional and context-dependent.
positive regulation of blood vessel endothelial cell migration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| B7-H3 / NF-κB / VEGFA | Colorectal cancer angiogenesis | Endothelial migration assay with B7-H3 knockdown or NF-κB inhibition |
| ALOX12 | Tumor-associated high endothelial venule remodeling and lymph node immune evasion | Knockout or overexpression in endothelial or tumor models |
| CCR7 / CD8 | Hepatocellular carcinoma immunotherapy response | Combination anti-angiogenic and immune checkpoint blockade models |
| B2M | Pulmonary hypertension in HFpEF | Proteomics-guided knockout or knockdown in pulmonary endothelial cells |
| LRRC8A | Cardiac hypertrophy and coronary angiogenesis | Endothelial-specific knockout in pressure overload models |
Cancer and tumor angiogenesis
Tumors often hijack positive regulation of blood vessel endothelial cell migration to build a blood supply. B7-H3 promotes colorectal cancer angiogenesis by activating NF-κB and inducing VEGFA, which drives endothelial migration. High endothelial venule remodeling in tumor-associated lymph nodes can support immune evasion via ALOX12, while anti-angiogenic therapy combined with immune checkpoint blockade can promote CCR7+ CD8+ T-cell entry into hepatocellular carcinoma through high endothelial venules. These findings position GO:0043536 as a central node in tumor vascular biology and immunotherapy response.
Pulmonary hypertension and heart failure
Plasma proteomics has identified B2M as a regulator of pulmonary hypertension in heart failure with preserved ejection fraction, linking systemic and vascular biology to endothelial function. Endothelial LRRC8A promotes coronary angiogenesis and mitigates pressure overload-induced cardiac hypertrophy, indicating that positive regulation of endothelial migration can be protective in the heart. Dysregulation of these pathways may contribute to maladaptive vascular remodeling in cardiopulmonary disease.
Vascular development and repair
During development and tissue repair, positive regulation of blood vessel endothelial cell migration is required for sprouting angiogenesis and the formation of functional vascular networks. BMPR2-dependent tip-cell behavior and filopodia formation are essential for correct sprout guidance. Understanding these mechanisms may inform strategies to promote therapeutic angiogenesis in ischemic disease or to limit excessive neovascularization in other contexts [2,5].
From positive regulation of blood vessel endothelial cell migration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce endothelial migration? | CRISPR knockout in primary endothelial cells or immortalized endothelial lines [1,5] |
| Does a specific point mutation alter pro-migratory signaling? | Point-mutation knock-in in endothelial cells or zebrafish |
| Does overexpression of a pro-angiogenic factor increase migration? | Overexpression of VEGFA or B7-H3 in tumor or endothelial cells |
| How does a tagged protein localize during migration? | Tagged knock-in of BMPR2 or LRRC8A for live imaging [5,7] |
| Which genes are required for high endothelial venule remodeling? | CRISPR library screening in endothelial or immune-vascular co-culture models [3,6] |
| Can a miRNA mimic or inhibitor modulate migration? | miRNA overexpression or inhibition in tumor-endothelial co-culture |
How to Study the positive regulation of blood vessel endothelial cell migration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Number of endothelial cells migrating through a membrane | Testing pro-migratory effects of VEGFA or candidate genes |
| Scratch-wound assay | Rate of endothelial monolayer closure | Quantifying positive regulation of endothelial migration |
| Live-cell imaging | Filopodia dynamics and tip-cell behavior | Studying BMPR2-dependent migration |
| RNA-seq | Transcriptional changes during migration | Identifying pro-angiogenic gene signatures |
| Proteomics | Protein abundance and post-translational changes | Discovering biomarkers such as B2M in pulmonary hypertension |
| CRISPR library screening | Genes required for endothelial migration | Unbiased discovery of positive regulators [3,6] |
| miRNA profiling | Post-transcriptional regulators of migration | Tumor-endothelial crosstalk studies |
| Co-culture assays | Immune-endothelial interactions | High endothelial venule and T-cell entry models [3,6] |
Endothelial migration assays
Transwell, scratch-wound and microfluidic migration assays are standard methods to quantify the frequency, rate and directionality of endothelial cell movement. These assays can be combined with siRNA or CRISPR perturbation to test whether a candidate gene positively regulates blood vessel endothelial cell migration [1,5]. Live-cell imaging provides additional information on filopodia dynamics and tip-cell behavior.
Transcriptomic and proteomic profiling
RNA-seq and proteomics can identify genes and proteins whose expression changes during endothelial migration or in response to pro-angiogenic stimuli. Plasma proteomics has been used to identify B2M as a regulator of pulmonary hypertension in HFpEF. Such datasets can be interrogated for GO:0043536 annotations to prioritize functional candidates [4,5].
Imaging and biomechanics
Live imaging of endothelial sprouting, filopodia formation and tip-cell position is essential for understanding the spatial control of migration. BMPR2 expression and signaling are required for correct tip-cell position and biomechanics, and these features can be measured using high-resolution microscopy and traction force microscopy. Tagged knock-in models enable visualization of endogenous proteins during migration [5,7].
Functional screens and bioinformatics
CRISPR library screening and bioinformatics analysis can systematically identify positive regulators of endothelial migration. High endothelial venule remodeling and immune-vascular crosstalk can be studied using co-culture systems and single-cell transcriptomics [3,6]. miRNA screens can reveal post-transcriptional regulators of tumor-endothelial interactions.
How CRISPR Can Be Used to Study GO:0043536 positive regulation of blood vessel endothelial cell migration
Knockout
CRISPR knockout of candidate genes such as LRRC8A or B7-H3 can test whether they are required for positive regulation of blood vessel endothelial cell migration. Endothelial-specific knockout in mice or knockout in primary endothelial cells followed by migration assays provides causal evidence [1,5]. Knockout of BMPR2 can reveal its role in tip-cell position and filopodia formation.
Point Mutation
Point-mutation knock-in can model disease-associated variants or phospho-null/phospho-mimetic mutations in genes such as BMPR2 or LRRC8A. These models help determine whether specific residues are required for pro-migratory signaling and biomechanics [5,7]. Point mutations can also be used to dissect NF-κB-dependent VEGFA induction.
Knock-in
Tagged knock-in of endogenous genes, for example with fluorescent or epitope tags, enables live imaging of protein localization during endothelial migration. This approach is valuable for studying BMPR2 trafficking and LRRC8A channel localization [5,7]. Knock-in of reporter cassettes can also monitor VEGFA promoter activity in response to B7-H3 signaling.
Overexpression
Overexpression of pro-migratory factors such as VEGFA or B7-H3 can increase endothelial migration and angiogenesis in vitro and in vivo. Overexpression of miRNAs or their inhibitors can modulate tumor-endothelial crosstalk and migratory behavior. These models are useful for gain-of-function studies and for validating therapeutic targets.
How EDITGENE Supports positive regulation of blood vessel endothelial cell migration Research
Researchers studying positive regulation of blood vessel endothelial cell migration-related genes often need to determine whether a candidate gene is causally involved in endothelial motility or simply correlated with angiogenic phenotypes. Rigorous causal inference requires precise genetic perturbation, ideally with multiple complementary models that control for off-target effects and expression artifacts. EDITGENE provides end-to-end CRISPR services tailored to vascular biology, from knockout and point-mutation models to knock-in reporters, overexpression lines and library screening, supported by bioinformatics analysis of migration and angiogenesis datasets.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of blood vessel endothelial cell migration research.
Frequently Asked Questions About positive regulation of blood vessel endothelial cell migration
What is GO:0043536?
GO:0043536 is the Gene Ontology term for positive regulation of blood vessel endothelial cell migration, defined as any process that activates or increases the frequency, rate or extent of endothelial cell migration in blood vessels.
What genes are involved in positive regulation of blood vessel endothelial cell migration?
Key genes include VEGFA, NF-κB, B7-H3, BMPR2, LRRC8A, B2M, ALOX12, CCR7 and various miRNAs, as reported in the verified literature [1,3,4,5,6,7,8].
How is endothelial cell migration regulated during angiogenesis?
It is regulated by growth factors such as VEGFA, transcription factors such as NF-κB, mechanotransduction pathways involving BMPR2, ion channels such as LRRC8A and post-transcriptional regulators such as miRNAs [1,5,7,8].
Why is positive regulation of blood vessel endothelial cell migration important in cancer?
Tumors use pro-migratory signals to build new blood vessels, and B7-H3-driven NF-κB/VEGFA signaling promotes colorectal cancer angiogenesis. High endothelial venule remodeling can also support immune evasion.
What diseases are linked to GO:0043536?
It has been linked to cancer, pulmonary hypertension in HFpEF, cardiac hypertrophy and immune evasion in lymph nodes [1,3,4,5].
What experimental models are used to study endothelial migration?
Common models include Transwell and scratch-wound assays, live-cell imaging, RNA-seq, proteomics, CRISPR knockout and overexpression in endothelial cells [1,4,5,7].
How does BMPR2 affect endothelial cell migration?
BMPR2 expression and signaling are required for correct endothelial tip-cell position, filopodia formation and biomechanics, which are essential for directed migration.
Can CRISPR be used to study positive regulation of blood vessel endothelial cell migration?
Yes, CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression models can test causal roles of candidate genes in endothelial migration [1,5,7].
What is the role of LRRC8A in coronary angiogenesis?
Endothelial LRRC8A promotes coronary angiogenesis and mitigates pressure overload-induced cardiac hypertrophy.
How can I screen for novel regulators of endothelial migration?
Pooled CRISPR library screening combined with migration assays and bioinformatics can identify novel positive regulators of blood vessel endothelial cell migration [3,6].
Conclusion
GO:0043536, positive regulation of blood vessel endothelial cell migration, is a central biological process in angiogenesis and vascular remodeling. The verified literature highlights VEGFA, NF-κB, B7-H3, BMPR2, LRRC8A, B2M, ALOX12 and miRNAs as key players, with disease relevance spanning cancer, pulmonary hypertension, cardiac hypertrophy and immune evasion [1,3,4,5,6,7,8]. Understanding these mechanisms requires precise genetic models and functional assays. EDITGENE's CRISPR services, including knockout, point mutation, knock-in, overexpression and library screening, provide the tools needed to dissect this process and translate findings into therapeutic strategies.
References
- 1. Wang R et al.. 2020. B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression.. Cell Death Dis 11(1):55 PMID: 31974361
- 2. Patan S. 2004. Vasculogenesis and angiogenesis.. Cancer Treat Res 117:3-32 PMID: 15015550
- 3. Xia Q et al.. 2026. Tumour-associated high endothelial venules drive portal-specific immune evasion in lymph nodes via ALOX12.. Nat Commun 17(1) PMID: 42115618
- 4. Jheng JR et al.. 2024. Plasma Proteomics Identifies B2M as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction.. Arterioscler Thromb Vasc Biol 44(7):1570-1583 PMID: 38813697
- 5. Jie L et al.. 2025. Endothelial LRRC8A mitigates pressure overload-induced cardiac hypertrophy by promoting coronary angiogenesis.. Angiogenesis 29(1):7 PMID: 41353685
- 6. Tang L et al.. 2026. Anti-angiogenic therapy combined with immune checkpoint blockade mediates CCR7 + CD8 + T-cell entry into HCC through high endothelial venules.. Hepatology 84(1):57-73 PMID: 40513067
- 7. Hiepen C et al.. 2025. Endothelial tip-cell position, filopodia formation and biomechanics require BMPR2 expression and signaling.. Commun Biol 8(1):21 PMID: 39779836
- 8. Orso F et al.. 2020. Role of miRNAs in tumor and endothelial cell interactions during tumor progression.. Semin Cancer Biol 60:214-224 PMID: 31386907
